Market Place
Sourcing Support
ProPhase Labs Launches BE-Smart Sale, Advances Crown Initiative
03 Feb 2026 //
GLOBENEWSWIRE
Prophase Labs Hosts Live Investor Webinar On February 3
02 Feb 2026 //
GLOBENEWSWIRE
Prophase Labs Uplists From Pink Sheets To OTC Market
22 Jan 2026 //
GLOBENEWSWIRE
ProPhase Labs Updates on Debt Conversions and Capital Structure
05 Jan 2026 //
GLOBENEWSWIRE
Prophase Labs Enters Non-Binding LOI For Reverse Merger
19 Dec 2025 //
GLOBENEWSWIRE
Prophase Labs Hosts Live Investor Webinar On December 1
26 Nov 2025 //
GLOBENEWSWIRE
Prophase Labs To Report Q3 2025 Results, Host Virtual Conference
19 Nov 2025 //
GLOBENEWSWIRE
Prophase Labs Urges Shareholders To Vote On Proxy Proposals
17 Nov 2025 //
GLOBENEWSWIRE
Prophase Labs Publishes Be-Smart Esophageal Cancer Study
29 Oct 2025 //
GLOBENEWSWIRE
ProPhase Labs Reports Financial Results for H1 2025
13 Aug 2025 //
GLOBENEWSWIRE
ProPhase Labs Gets USPTO Patent for Esophageal Adenocarcinoma
12 Aug 2025 //
GLOBENEWSWIRE
ProPhase Labs Closes $3M Secured Convertible Notes Financing
23 Jul 2025 //
GLOBENEWSWIRE
ProPhase Labs Explores Reverse Merger, Approves Crypto Initiative
21 Jul 2025 //
GLOBENEWSWIRE
ProPhase Labs Study Shows BE-Smart Test Detects Esophageal Cancer
17 Jun 2025 //
GLOBENEWSWIRE
ProPhase Labs Names Stuart Hollenshead As New COO
18 Feb 2025 //
GLOBENEWSWIRE
ProPhase Labs to Present at the 2024 ThinkEquity Conference
22 Oct 2024 //
GLOBENEWSWIRE
ProPhase Labs Announces Q2 2024 Financial Results Ending June 30, 2024
14 Aug 2024 //
GLOBENEWSWIRE
PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14
07 Aug 2024 //
GLOBENEWSWIRE
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
11 Jul 2024 //
GLOBENEWSWIRE
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
02 May 2024 //
GLOBENEWSWIRE
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023
15 Mar 2024 //
GLOBENEWSWIRE
Prophase Labs To Present 2023 Year End Financial Results On March 15, 2024
08 Mar 2024 //
GLOBENEWSWIRE
ProPhase Announces Preliminary Positive Results for Dietary Supplement Equivir
14 Feb 2024 //
GLOBENEWSWIRE
Pharmaloz Manufacturing Accelerates Expansion and Secures New Contracts
23 Jan 2024 //
GLOBENEWSWIRE
ProPhase Announces Growth Expectations for Pharmaloz Manufacturing Subsidiary
17 Oct 2023 //
GLOBENEWSWIRE
ProPhase and Dana-Farber Cancer Institute partner for LB-1 development
09 Nov 2022 //
PHARMACEUTICAL-TECHNOLOGY
ProPhase Labs Announces New $6 Million Stock Repurchase Plan
26 Jul 2022 //
PRESS RELEASE
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds
21 Jul 2022 //
PRESS RELEASE
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 Jul 2022 //
PRESS RELEASE
ProPhase Labs to Host Live Webcast to Discuss Business Developments
19 Jul 2022 //
PRESS RELEASE
